UNSPSC 51143709: Diphenhydramine/ibuprofen

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143709 Diphenhydramine/ibuprofen is a Commodity code that shows minimal relevant recent activity—the most recent state and local opportunities tagged under this code solicit naloxone and drug deactivation systems (Seminole County), therapeutic pharmacy initiatives and direct-to-manufacturer prescription programs (Texas HHS), and generic multi-source pharmaceuticals and OTC products broadly (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations target diphenhydramine or ibuprofen specifically, signaling either a mismatch between the code classification and actual procurement, or that state and local governments are not actively buying these products through formal solicitation at this time. The code does not appear in any recent RFP, RFQ, IFB, or ITB targeting combination analgesics or antihistamines as named line items.

Without representative recent opportunities clearly aligned to the code's nominal scope, the code offers limited actionable procurement intelligence for business development professionals evaluating state and local activity. The broader pharmaceutical and OTC product sourcing shown in the tagged opportunities is managed through cooperative purchasing vehicles (MMCAP in Minnesota and Oregon), individual health agency RFIs (Texas HHS), and county-level competitive bidding (Seminole County), but none specifically address diphenhydramine/ibuprofen as a target product. Firms supplying these products should monitor cooperative purchasing agreements and state health department OTC and generic pharmaceutical procurement broadly rather than focus on this Commodity code alone.